Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

Proposed Public Offering: Applied Genetic Technologies Corp. (AGTC) stock Collapse After Hours

By
Published On January 1, 1970 12:00 AM UTC
Proposed Public Offering: Applied Genetic Technologies Corp. (AGTC) stock Collapse After Hours

On March 21, 2022, Applied Genetic Technologies Corp. (AGTC) announced a proposed underwritten public offering. While already being in the red, the stock collapsed in the after-hours following the announcement from the company.

In the regular trading session, AGTC declined by 4.26% after fluctuating between $1.78 and $1.88. At the close of the session, the stock had a price of $1.80 per share while the volume of the shares exchanged was 662.74K. The session’s volume was above the average at 147%. Following the announcement, the stock took a further hit as it plunged down by a huge 20.56% in the after-hours session. Thus, AGTC stock was trading at a value of $1.43 per share in the after-hours on Monday.

The clinical-stage biotechnology company, Applied Genetic Technologies Corp. has a market capitalization of $80.69 million. Founded in 1999, the company has 42.92 million shares outstanding in the market currently. AGTC stock stands at a year-to-date loss of 5.26% while it has gained 11.11% in the past five days.

AGTC’s Public Offering

On Monday, the company declared the initiation of a proposed underwritten public offering of its common stock. Moreover, the company also plans to offer a 30-day option for buying an additional 15% of common stock shares in the original offering, to the underwriter.

The company plans to use the net proceeds from the offering for funding its ongoing Skyline and Vista clinical trials along with Phase ½ trials in the ACHM program. Further, a part of the proceeds will also be used for working capital and general corporate purposes.

Additionally, the sole book-running manager for the offering to the company is Cantor Fitzgerald & Co. The actual size, terms, and complete details of the offering were not provided.

Upcoming Conferences

As announced on March 8, the company’s management will be presenting at certain upcoming investor conferences.

AGTC’s CEO and president Sue Washer will be participating in a panel discussion at the Cantor Fitzgerald Virtual Rare Orphan Disease Summit. The panel discussion will take place on March 29 during the conference.

Furthermore, Ms. Washer will also participate in a fireside chat at the H.C. Wainwright Gene Therapy and Gene Editing Conference on March 30.

AGTC’s Q4 2021 Highlights

In Q4 2021, the company incurred a net loss of $19.1 million against $15.5 million in the year-ago quarter.

AGTC ended the quarter with cash and cash equivalents of $72.8 million which the company believes will provide runway into 2023.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph